Ameritas Investment Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Ameritas Investment Partners’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,558	Closed	-$465K	–	3259
2023 Q1	$465K	Buy	2,558 +189	+8%	+$36.1K	0.02%	777
2022 Q4	$466K	Buy	2,369 +28	+1%	+$6K	0.02%	800
2022 Q3	$526K	Buy	2,341 +369	+19%	+$74.7K	0.02%	738
2022 Q2	$249K	Buy	1,972 +231	+13%	+$26.5K	0.01%	954
2022 Q1	$221K	Hold	1,741	–	–	0.01%	1125
2021 Q4	$228K	Hold	1,741	–	–	0.01%	1147
2021 Q3	$213K	Hold	1,741	–	–	0.01%	1158
2021 Q2	$198K	Buy	1,741 +456	+35%	+$53.3K	0.01%	1259
2021 Q1	$154K	Sell	1,285 -85	-6%	-$9.63K	0.01%	1381
2020 Q4	$139K	Hold	1,370	–	–	0.01%	1367
2020 Q3	$106K	Hold	1,370	–	–	﹤0.01%	1392
2020 Q2	$153K	Buy	1,370 +460	+51%	+$40K	0.01%	1158
2020 Q1	$66K	Buy	910 +530	+139%	+$45.3K	﹤0.01%	1517
2019 Q4	$29K	Hold	380	–	–	﹤0.01%	2227
2019 Q3	$6K	Buy	+380	New	+$7.38K	﹤0.01%	2912

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameritas Investment Partners's KRTX Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2023, closing a stake of 2,558 shares — an estimated $465K sold.

Ameritas Investment Partners first reported a position in KRTX in Q3 2019 and held it in 15 quarters. The position peaked at $526K in Q3 2022. 289 funds tracked by Wall St. Rank hold KRTX as of Q2 2023.

Ameritas Investment Partners reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ameritas Investment Partners sold 2,558 Karuna Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $465K.
Ameritas Investment Partners first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 15 quarters.
Ameritas Investment Partners's Karuna Therapeutics, Inc. Common Stock position peaked at $526K in Q3 2022.
289 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.